Literature DB >> 16052909

Experimental models of acute and chronic liver failure in nude mice to study hepatocyte transplantation.

Amaud Gandillet1, Isabelle Vidal, Eliane Alexandre, Maxime Audet, Marie-Pierre Chenard-Neu, Jeanne Stutzmann, Bruno Heyd, Daniel Jaeck, Lysiane Richert.   

Abstract

Although hepatocyte transplantation is a promising therapy for acute liver failure in human, there is still a lack of animal models suffering from hepatic injury in which the benefits of hepatocyte transplantation could be evaluated solely, without the bias caused by immunosuppression. As a consequence, the aim of the study was first to develop reproducible models of partial hepatectomy and of thioacetamide (TA)- or Jo2-induced acute liver failure in nude mice. Chronic liver disease was also investigated by repeated injections of sublethal doses of thioacetamide. Survival rates, routine histologic observations, alanin aminotransferase sera content, Ki67, and caspase 3 immunodetection were investigated both after 40% partial hepatectomy and after toxic-induced damages. Liver injuries were more severe and/or precocious in nude mice than in Balb/c mice for a given treatment with a maximum of acute injury obtained 24 h after single toxic injection, and were found to be transitory and reversible within 10 days. Toxics induced apoptosis followed by necrosis, confirming recent published data. Onset of fibrosis leading to reproducible chronic cirrhosis in nude mice correlated with increasing number of Ki67-positive cells, indicating that high levels of cell proliferation occurred. Chronic cirrhosis progressively reversed to fibrosis when the treatment ceased. Preliminary results demonstrated that engrafted xenogeneic hepatocytes could be detected in the host liver by anti-MHC class I immunohistochemistry. Fractions enriched in 2n or 4n hepatocytes by cell sorting using a flow cytometer were equivalent to the unpurified fraction in terms of engraftment in control nude mice or in nude mice subjected to PH. However, in mice suffering from liver injury 24 h after Jo2 or TA treatment, the engraftment of 2n hepatocytes was about twice that of an unpurified hepatocyte population or of a population enriched in 4n hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052909     DOI: 10.3727/000000005783983061

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  5 in total

1.  Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes.

Authors:  Benoit Lacoste; Valérie-Ann Raymond; Pascal Lapierre; Marc Bilodeau
Journal:  PLoS One       Date:  2016-10-28       Impact factor: 3.240

2.  An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1.

Authors:  Daniel Doheny; Sara Manore; Sherona R Sirkisoon; Dongqin Zhu; Noah R Aguayo; Alexandria Harrison; Mariana Najjar; Marlyn Anguelov; Anderson O'Brien Cox; Cristina M Furdui; Kounosuke Watabe; Thomas Hollis; Alexandra Thomas; Roy Strowd; Hui-Wen Lo
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

3.  The nude mouse as model for liver deficiency study and treatment and xenotransplantation.

Authors:  Isabelle Vidal; Lysiane Richert
Journal:  Int J Hepatol       Date:  2012-10-31

4.  Dietary α-Mangostin Provides Protective Effects against Acetaminophen-Induced Hepatotoxicity in Mice via Akt/mTOR-Mediated Inhibition of Autophagy and Apoptosis.

Authors:  Xiao-Tong Yan; Yin-Shi Sun; Shen Ren; Li-Chun Zhao; Wen-Cong Liu; Chen Chen; Zi Wang; Wei Li
Journal:  Int J Mol Sci       Date:  2018-05-01       Impact factor: 5.923

5.  Maltol Improves APAP-Induced Hepatotoxicity by Inhibiting Oxidative Stress and Inflammation Response via NF-κB and PI3K/Akt Signal Pathways.

Authors:  Zi Wang; Weinan Hao; Junnan Hu; Xiaojie Mi; Ye Han; Shen Ren; Shuang Jiang; Yingping Wang; Xindian Li; Wei Li
Journal:  Antioxidants (Basel)       Date:  2019-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.